George D. Yancopoulos
Overview
George D. Yancopoulos received an average of $30M in total compensation, including $921K in salary, at Regeneron Pharmaceuticals from 2006 to 2021.
2021Regeneron PharmaceuticalsPresident and Chief Scientific Officer
2020Regeneron PharmaceuticalsPresident and Chief Scientific Officer
2019Regeneron PharmaceuticalsPresident and Chief Scientific Officer
2018Regeneron PharmaceuticalsPresident and Chief Scientific Officer
2017Regeneron PharmaceuticalsPresident and Chief Scientific Officer
2016Regeneron PharmaceuticalsPresident and Chief Scientific Officer
2015Regeneron PharmaceuticalsPresident, Regeneron Laboratories and Chief Scientific Officer
2014Regeneron PharmaceuticalsPresident, Regeneron Laboratories and Chief Scientific Officer
2013Regeneron PharmaceuticalsPresident, Regeneron Laboratories and Chief Scientific Officer
2012Regeneron PharmaceuticalsPresident, Regeneron Laboratories and Chief Scientific Officer
Related executives
We found ten more executives who work or worked at Regeneron Pharmaceuticals.
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
Joseph LaRosa
Regeneron Pharmaceuticals
General Counsel
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
Marion McCourt
Regeneron Pharmaceuticals
Senior Vice President, Commercial
Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
Robert Terifay
Regeneron Pharmaceuticals
Executive Vice President, Commercial
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019